Verastem, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +395.8%
EBITDA: -32.3%
EBIT: -30.3%
EPS: +30.0%
Free cash flow: -32.3%
Operating cash flow: -31.1%

Forward estimates

Revenue: +52.9%
EBITDA: +79.7%
EPS: +73.1%

Three-year CAGR

Revenue: +128.4%
EBITDA: -64.9%
EBIT: -48.0%
Net income: -60.3%
EPS: +17.5%
Free cash flow: -31.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.